LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 66.67 | 27.76 | 2210 | 6695 | 0.3301 | 0.7386 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 68.37 | 27.76 | 689 | 6879 | 0.1002 | 0.4975 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 68.37 | 27.76 | 1896 | 6879 | 0.2756 | 0.7008 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 68.37 | 27.76 | 983 | 6879 | 0.1429 | 0.5660 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 68.37 | 27.76 | 2268 | 6879 | 0.3297 | 0.7396 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 70.08 | 27.76 | 587 | 6849 | 0.0857 | 0.4681 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 70.08 | 27.76 | 1936 | 6849 | 0.2826 | 0.7060 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 70.08 | 27.76 | 761 | 6849 | 0.1111 | 0.5169 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 70.08 | 27.76 | 2278 | 6849 | 0.3326 | 0.7413 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 71.78 | 27.76 | 466 | 6893 | 0.0676 | 0.4255 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 71.78 | 27.76 | 1930 | 6893 | 0.2800 | 0.7043 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 71.78 | 27.76 | 507 | 6893 | 0.0736 | 0.4407 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 71.78 | 27.76 | 2340 | 6893 | 0.3395 | 0.7461 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 73.48 | 27.76 | 337 | 6957 | 0.0484 | 0.3679 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 73.48 | 27.76 | 1999 | 6957 | 0.2873 | 0.7103 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 73.48 | 27.76 | 466 | 6957 | 0.0670 | 0.4247 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 73.48 | 27.76 | 2362 | 6957 | 0.3395 | 0.7465 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 75.19 | 27.76 | 293 | 7015 | 0.0418 | 0.3435 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 75.19 | 27.76 | 2021 | 7015 | 0.2881 | 0.7113 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 75.19 | 27.76 | 431 | 7015 | 0.0614 | 0.4100 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 75.19 | 27.76 | 2424 | 7015 | 0.3455 | 0.7507 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.89 | 27.76 | 205 | 7025 | 0.0292 | 0.2846 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.89 | 27.76 | 2038 | 7025 | 0.2901 | 0.7128 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.89 | 27.76 | 210 | 7025 | 0.0299 | 0.2885 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.89 | 27.76 | 2490 | 7025 | 0.3544 | 0.7563 | MN20160318_Q01 | G04 |